Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Development and internal validation of a risk model for hyperuricemia among people living with HIV in Hangzhou, China: a retrospective longitudinal cohort study.Frontiers in endocrinology · 2026
   Article
2. Construction and validation of a transmembrane 4 superfamily-related genes prognostic model for esophageal squamous cell carcinoma.Frontiers in oncology · 2025
   Article
3. Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer.Journal of translational medicine · 2024
   Review
4. Recent progress of ferroptosis in cancers and drug discovery.Asian journal of pharmaceutical sciences · 2024
   Review
5. Ferroptosis: mechanism, immunotherapy and role in ovarian cancer.Frontiers in immunology · 2024
   Review
6. Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential.Cell death discovery · 2023
   Review
7. Anti-ferroptoticJournal of gastrointestinal oncology · 2023
   Article
8. Recent trends in emerging strategies for ferroptosis-based cancer therapy.Nanoscale advances · 2023
   Review
9. A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.BMC urology · 2023
   Article
10. Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer.Vaccines · 2023
    Article
11. The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer.Frontiers in genetics · 2023
    Review
12. Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc.Scientific reports · 2022
    Article
13. A Novel Predictive Model for Adrenocortical Carcinoma Based on Hypoxia- and Ferroptosis-Related Gene Expression.Frontiers in medicine · 2022
    Article
14. Current progress of ferroptosis study in ovarian cancer.Frontiers in molecular biosciences · 2022
    Review
15. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.Frontiers in immunology · 2022
    Review
16. Roles of ferroptosis in urologic malignancies.Cancer cell international · 2021
    Review
17. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.Bioengineered · 2021
    Article
18. Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy.Frontiers in oncology · 2021
    Review
19. Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma.Journal of oncology · 2021
    Review
20. Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma.Frontiers in genetics · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as